Terms: = Endocrine gland cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
135 results:
1. Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Zhou Q; Tu X; Hou X; Yu J; Zhao F; Huang J; Kloeber J; Olson A; Gao M; Luo K; Zhu S; Wu Z; Zhang Y; Sun C; Zeng X; Schoolmeester KJ; Weroha JS; Hu X; Jiang Y; Wang L; Mutter RW; Lou Z
Drug Resist Updat; 2024 May; 74():101085. PubMed ID: 38636338
[TBL] [Abstract] [Full Text] [Related]
2. Atorvastatin-loaded cubosome: a repurposed targeted delivery systems for enhanced targeting against breast cancer.
El-Marakby EM; Fayez H; Motaleb MA; Mansour M
Pharm Dev Technol; 2024 Mar; 29(3):236-247. PubMed ID: 38451055
[TBL] [Abstract] [Full Text] [Related]
3. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
4. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
5. Suppression of nbs1 Upregulates CyclinB to Induce Olaparib Sensitivity in Ovarian cancer.
Zhong A; Cheng CS; Lu RQ; Guo L
Technol Cancer Res Treat; 2024; 23():15330338231212085. PubMed ID: 38192153
[No Abstract] [Full Text] [Related]
6. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL
Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901
[TBL] [Abstract] [Full Text] [Related]
7. Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors.
Bechmann N; Moskopp ML; Constantinescu G; Stell A; Ernst A; Berthold F; Westermann F; Jiang J; Lui L; Nowak E; Zopp S; Pacak K; Peitzsch M; Schedl A; Reincke M; Beuschlein F; Bornstein SR; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2024 Jan; 109(2):471-482. PubMed ID: 37647861
[TBL] [Abstract] [Full Text] [Related]
8. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract] [Full Text] [Related]
9.
Ramos CRN; Oliveira RJS; Rosa MN; Pereira AS; de Abreu RBV; van Helvoort Lengert A; Reis RM; Silva VAO; Palmero EI; Melendez ME
Curr Cancer Drug Targets; 2023; 23(11):900-909. PubMed ID: 37076963
[TBL] [Abstract] [Full Text] [Related]
10. Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan.
Prokofyeva DS; Mingazheva ET; Valova YV; Sakaeva DD; Faishanova RR; Nurgalieva AK; Valiev RR; Bogdanova N; Dörk T; Khusnutdinova EK
J Ovarian Res; 2023 Apr; 16(1):66. PubMed ID: 37013556
[TBL] [Abstract] [Full Text] [Related]
11. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
[TBL] [Abstract] [Full Text] [Related]
12. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
13. Adult Thyroid Outcomes of Congenital Hypothyroidism.
Sugisawa C; Narumi S; Tanase-Nakao K; Hoshiyama A; Suzuki N; Ohye H; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Sugino K; Hishinuma A; Noh JY; Katoh R; Taniyama M; Ito K
Thyroid; 2023 May; 33(5):556-565. PubMed ID: 36792927
[No Abstract] [Full Text] [Related]
14. Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.
Lee SS; Karpel HC; Oh C; Smith J; Pothuri B
Gynecol Oncol; 2023 Mar; 170():234-240. PubMed ID: 36724586
[TBL] [Abstract] [Full Text] [Related]
15. nbn Pathogenic Germline Variants are Associated with Pan-cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract] [Full Text] [Related]
16. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract] [Full Text] [Related]
17. Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer.
Coelho R; Tozzi A; Disler M; Lombardo F; Fedier A; López MN; Freuler F; Jacob F; Heinzelmann-Schwarz V
Cell Death Dis; 2022 Oct; 13(10):909. PubMed ID: 36307400
[TBL] [Abstract] [Full Text] [Related]
18. Moderate-Risk Genes for Hereditary Ovarian cancers Involved in the Homologous Recombination Repair Pathway.
Abe A; Imoto I; Ueki A; Nomura H; Kanao H
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233090
[TBL] [Abstract] [Full Text] [Related]
19. A ferrocene-containing nucleoside analogue targets DNA replication in pancreatic cancer cells.
Rana M; Perotti A; Bisset LM; Smith JD; Lamden E; Khan Z; Ismail MK; Ellis K; Armstrong KA; Hodder SL; Bertoli C; Meneguello L; de Bruin RAM; Morris JR; Romero-Canelon I; Tucker JHR; Hodges NJ
Metallomics; 2022 Jul; 14(7):. PubMed ID: 35689667
[TBL] [Abstract] [Full Text] [Related]
20. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
[Next]
